1,107
Views
14
CrossRef citations to date
0
Altmetric
Research Papers

Nifurtimox reduces N-Myc expression and aerobic glycolysis in neuroblastoma

, , &
Pages 1353-1363 | Received 24 Feb 2015, Accepted 03 Jul 2015, Published online: 08 Aug 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Parmida Sadat Pezeshki, Aysan Moeinafshar, Faezeh Ghaemdoust, Sepideh Razi, Mahsa Keshavarz-Fathi & Nima Rezaei. (2021) Advances in pharmacotherapy for neuroblastoma. Expert Opinion on Pharmacotherapy 22:17, pages 2383-2404.
Read now

Articles from other publishers (13)

Zhizhi Pan, Chenchen Zhou, Xuexin Bai, Fangfang Wang, Jie Hong, Jing-Yuan Fang, Yahui Huang & Chunquan Sheng. (2023) Discovery of New Fusobacterium nucleatum Inhibitors to Attenuate Migratory Capability of Colon Cancer Cells by the Drug Repositioning Strategy . Journal of Medicinal Chemistry.
Crossref
Don Eslin, Peter E. Zage, Genevieve Bergendahl, Elizabeth Lewis, William Roberts, Jacqueline Kraveka, Deanna Mitchell, Michael S. Isakoff, Jawhar Rawwas, Randal K. Wada, Mark Fluchel, Valerie I. Brown, Kevin Ginn, Timothy Higgins, Abhinav BeeravallyNagulapally, Karl Dykema, Gina Hanna, William Ferguson & Giselle L. Saulnier Sholler. (2023) A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastoma . International Journal of Cancer 153:5, pages 1026-1034.
Crossref
Narimantas Čėnas, Aušra Nemeikaitė-Čėnienė & Lidija Kosychova. (2021) Single- and Two-Electron Reduction of Nitroaromatic Compounds by Flavoenzymes: Mechanisms and Implications for Cytotoxicity. International Journal of Molecular Sciences 22:16, pages 8534.
Crossref
Atif Zafar, Wei Wang, Gang Liu, Xinjie Wang, Wa Xian, Frank McKeon, Jennifer Foster, Jia Zhou & Ruiwen Zhang. (2020) Molecular targeting therapies for neuroblastoma: Progress and challenges. Medicinal Research Reviews 41:2, pages 961-1021.
Crossref
Kimberly J. Ornell, Katelyn S. Mistretta, Coulter Q. Ralston & Jeannine M. Coburn. (2021) Development of a stacked, porous silk scaffold neuroblastoma model for investigating spatial differences in cell and drug responsiveness. Biomaterials Science 9:4, pages 1272-1290.
Crossref
Qiuxia Zhang, Zhenshuai Chen, Wei Yuan, Yu-Qing Tang, Jiangli Zhu, Wentao Wu, Hongguang Ren, Hui Wang, Weiyi Zheng, Zhongjian Zhang & Eryan Kong. (2021) Nifurtimox Hampered the Progression of Astroglioma In vivo Via Manipulating the AKT-GSK3β axis. Current Molecular Medicine 20:9, pages 723-732.
Crossref
Xiao Zhang, Jian Zhang, Qian Liu, Yuehua Zhao, Wenhua Zhang & Haiyan Yang. (2020) Circ-CUX1 Accelerates the Progression of Neuroblastoma via miR-16-5p/DMRT2 Axis. Neurochemical Research 45:12, pages 2840-2855.
Crossref
Hisham F. Bahmad, Mohamad K. Elajami, Talal El Zarif, Jolie Bou-Gharios, Tamara Abou-Antoun & Wassim Abou-Kheir. (2020) Drug repurposing towards targeting cancer stem cells in pediatric brain tumors. Cancer and Metastasis Reviews 39:1, pages 127-148.
Crossref
Christian Bailly. (2019) Toward a repositioning of the antibacterial drug nifuroxazide for cancer treatment. Drug Discovery Today 24:9, pages 1930-1936.
Crossref
Sepideh Aminzadeh-Gohari, René Günther Feichtinger & Barbara Kofler. 2019. Neuroblastoma. Neuroblastoma 113 132 .
Akira Nakagawara, Yuanyuan Li, Hideki Izumi, Katsumi Muramori, Hiroko Inada & Masanori Nishi. (2018) Neuroblastoma. Japanese Journal of Clinical Oncology 48:3, pages 214-241.
Crossref
Ye Li, Tian-tian Liu, Hong-tao Jin, Piao-piao Zhang, Dan Qin, Qian-qian Zhang, Wen-tao Wu, Cui-ping Yang & Ai-ping Wang. (2017) A comparison of toxicity and toxicokinetics in rats and dogs following twenty-eight-day, repeat-dose oral administration of nifurtimox. Toxicology Research 6:4, pages 544-553.
Crossref
Francesco Maria Calabrese, Rosanna Clima, Piero Pignataro, Vito Alessandro Lasorsa, Michael D. Hogarty, Aurora Castellano, Massimo Conte, Gian Paolo Tonini, Achille Iolascon, Giuseppe Gasparre & Mario Capasso. (2016) A comprehensive characterization of rare mitochondrial DNA variants in neuroblastoma. Oncotarget 7:31, pages 49246-49258.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.